ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
MindBio Therapeutics Corp

MindBio Therapeutics Corp (MBIO)

0.035
0.00
(0.00%)
終了 11月1日 5:00AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.035
買値
0.03
売値
0.035
出来高
9,858
0.035 日の範囲 0.035
0.015 52 週間の範囲 0.085
前日終値
0.035
始値
0.035
最終取引時間
平均取引量 (3 か月)
34,025
財務取引量
-
VWAP
-

MBIO 最新ニュース

Mindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With Depression

  MINDBIO THERAPEUTICS BEGINS DOSING MB22001 IN PHASE 2 CLINICAL TRIAL IN WORLD FIRST TAKE-HOME MICRODOSING STUDY IN PATIENTS WITH DEPRESSION World-first take-home approvals...

MindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of Sleep

MINDBIO THERAPEUTICS BREAKTHROUGH DISCOVERY IN MICRODOSING CLINICAL TRIAL REVEALS SIGNIFICANT POSITIVE EFFECTS ON QUALITY OF SLEEPNew Discovery:  MindBio's LSD-Microdosing Treatment Improves...

MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale

MINDBIO THERAPEUTICS CEO DEMONSTRATES HOW 1 MILLION MICRODOSES OF LSD CAN POTENTIALLY BE USED TO TREAT DEPRESSION 1 Million Microdoses used to create proprietary microdosing...

MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder

 ETHICS APPROVAL FOR LANDMARK WORLD FIRST PHASE 2 CLINICAL TRIAL OF TAKE-HOME LSD-MICRODOSING FOR MAJOR DEPRESSIVE DISORDEREthics approval received for take-home LSD-Microdosing clinical...

MindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional Distress

PHASE 2 CLINICAL TRIAL HAS RECEIVED ETHICS APPROVAL FOR WORLD FIRST TAKE-HOME LSD-MICRODOSING TRIALS IN CANCER PATIENTS EXPERIENCING EMOTIONAL DISTRESSEthics approval granted The clinical trial...

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants   MindBio clinical trial...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.00516.66666666670.030.0350.031560520.03279228CS
40.01400.0250.0350.025520100.0317023CS
120.00516.66666666670.030.040.025340250.03098647CS
26-0.02-36.36363636360.0550.070.025414260.0384308CS
520.01400.0250.0850.015448600.04298633CS
156-0.525-93.750.560.560.015611710.06345987CS
260-0.525-93.750.560.560.015611710.06345987CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VEJI.XVeji Holdings Inc
$ 0.04
(300.00%)
1,000
VBNPedro Resources Ltd
$ 0.06
(140.00%)
2k
SLZSlave Lake Zinc Corp
$ 0.035
(133.33%)
2.8k
TGIF1933 Industries Inc
$ 0.01
(100.00%)
40k
TRGTarachi Gold Corp
$ 0.025
(66.67%)
47k
MYCOMydecine Innovations Group Inc
$ 0.005
(-50.00%)
13k
WBGDWaraba Gold Limited
$ 0.005
(-50.00%)
1,000
RVVRevive Therapeutics Ltd
$ 0.005
(-50.00%)
525k
AWRAurwest Resources Corporation
$ 0.005
(-50.00%)
2k
CACRKWG Resources Inc
$ 0.01
(-50.00%)
13k
LEEFLeef Brands Inc
$ 0.025
(0.00%)
4.03M
CVGRCity View Green Holdings Inc
$ 0.01
(0.00%)
2.21M
HPSSHybrid Power Solutions Inc
$ 0.05
(66.67%)
1.92M
BLOXCryptoblox Technologies Inc
$ 0.175
(25.00%)
1.78M
PSYCPsyched Wellness Ltd
$ 0.015
(-25.00%)
1.33M

最近閲覧した銘柄

Delayed Upgrade Clock